186 related articles for article (PubMed ID: 20529839)
1. Factor VIII lacking the C2 domain retains cofactor activity in vitro.
Wakabayashi H; Griffiths AE; Fay PJ
J Biol Chem; 2010 Aug; 285(33):25176-84. PubMed ID: 20529839
[TBL] [Abstract][Full Text] [Related]
2. Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa.
Wakabayashi H; Fay PJ
J Biol Chem; 2013 Oct; 288(43):31289-97. PubMed ID: 24030831
[TBL] [Abstract][Full Text] [Related]
3. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets.
Saenko EL; Scandella D; Yakhyaev AV; Greco NJ
J Biol Chem; 1998 Oct; 273(43):27918-26. PubMed ID: 9774404
[TBL] [Abstract][Full Text] [Related]
4. Cofactor activity in factor VIIIa of the blood clotting pathway is stabilized by an interdomain bond between His281 and Ser524 formed in factor VIII.
Wakabayashi H; Monaghan M; Fay PJ
J Biol Chem; 2014 May; 289(20):14020-9. PubMed ID: 24692542
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional characterization of platelet receptor-mediated factor VIII binding.
Ahmad SS; Scandura JM; Walsh PN
J Biol Chem; 2000 Apr; 275(17):13071-81. PubMed ID: 10777612
[TBL] [Abstract][Full Text] [Related]
6. Modification of interdomain interfaces within the A3C1C2 subunit of factor VIII affects its stability and activity.
Wakabayashi H; Fay PJ
Biochemistry; 2013 Jun; 52(22):3921-9. PubMed ID: 23659383
[TBL] [Abstract][Full Text] [Related]
7. Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.
Jenkins PV; Dill JL; Zhou Q; Fay PJ
Biochemistry; 2004 May; 43(17):5094-101. PubMed ID: 15109268
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of factor VIII by factor IXa.
O'Brien DP; Johnson D; Byfield P; Tuddenham EG
Biochemistry; 1992 Mar; 31(10):2805-12. PubMed ID: 1547220
[TBL] [Abstract][Full Text] [Related]
9. Membrane-binding properties of the Factor VIII C2 domain.
Novakovic VA; Cullinan DB; Wakabayashi H; Fay PJ; Baleja JD; Gilbert GE
Biochem J; 2011 Apr; 435(1):187-96. PubMed ID: 21210768
[TBL] [Abstract][Full Text] [Related]
10. Factor VIII mutated with Lys1813Ala within the factor IXa-binding region enhances intrinsic coagulation potential.
Nakajima Y; Takeyama M; Oda A; Shimonishi N; Nogami K
Blood Adv; 2023 Apr; 7(8):1436-1445. PubMed ID: 36322904
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic stability and functional properties of disulfide bond-stabilized coagulation factor VIIIa variants.
Gale AJ; Radtke KP; Cunningham MA; Chamberlain D; Pellequer JL; Griffin JH
J Thromb Haemost; 2006 Jun; 4(6):1315-22. PubMed ID: 16706977
[TBL] [Abstract][Full Text] [Related]
12. A3 domain region 1803-1818 contributes to the stability of activated factor VIII and includes a binding site for activated factor IX.
Bloem E; Meems H; van den Biggelaar M; Mertens K; Meijer AB
J Biol Chem; 2013 Sep; 288(36):26105-26111. PubMed ID: 23884417
[TBL] [Abstract][Full Text] [Related]
13. Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesicles.
Duffy EJ; Parker ET; Mutucumarana VP; Johnson AE; Lollar P
J Biol Chem; 1992 Aug; 267(24):17006-11. PubMed ID: 1512239
[TBL] [Abstract][Full Text] [Related]
14. In vitro characterization of recombinant factor VIII concentrates reveals significant differences in protein content, activity and thrombin activation profile.
Pahl S; Pavlova A; Driesen J; Müller J; Pötzsch B; Oldenburg J
Haemophilia; 2013 May; 19(3):392-8. PubMed ID: 23252674
[TBL] [Abstract][Full Text] [Related]
15. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition.
Saenko EL; Shima M; Gilbert GE; Scandella D
J Biol Chem; 1996 Nov; 271(44):27424-31. PubMed ID: 8910322
[TBL] [Abstract][Full Text] [Related]
16. Factor VIII A3 domain residues 1793-1795 represent a factor IXa-interactive site in the tenase complex.
Takeyama M; Furukawa S; Sasai K; Horiuchi K; Nogami K
Biochim Biophys Acta Gen Subj; 2023 Aug; 1867(8):130381. PubMed ID: 37207906
[TBL] [Abstract][Full Text] [Related]
17. Membrane Interaction of the Factor VIIIa Discoidin Domains in Atomistic Detail.
Madsen JJ; Ohkubo YZ; Peters GH; Faber JH; Tajkhorshid E; Olsen OH
Biochemistry; 2015 Oct; 54(39):6123-31. PubMed ID: 26346528
[TBL] [Abstract][Full Text] [Related]
18. Disulfide bond-stabilized factor VIII has prolonged factor VIIIa activity and improved potency in whole blood clotting assays.
Radtke KP; Griffin JH; Riceberg J; Gale AJ
J Thromb Haemost; 2007 Jan; 5(1):102-8. PubMed ID: 17059431
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of thrombin-activated human factor VIII.
Curtis JE; Helgerson SL; Parker ET; Lollar P
J Biol Chem; 1994 Feb; 269(8):6246-51. PubMed ID: 8119969
[TBL] [Abstract][Full Text] [Related]
20. Increasing hydrophobicity or disulfide bridging at the factor VIII A1 and C2 domain interface enhances procofactor stability.
Wakabayashi H; Griffiths AE; Fay PJ
J Biol Chem; 2011 Jul; 286(29):25748-55. PubMed ID: 21628455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]